advertisement

Oculus

11.14 Investigational drugs; pharmacological experiments (106)

Showing records 1 to 25

Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments

Search within classification 11.14 Investigational drugs; pharmacological experiments
84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Yagi-Yaguchi Y
Diagnostics (Basel, Switzerland) 2020; 10:
84489 New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Mehran NA
Eye 2020; 34: 72-88
85112 Secondary Neuroprotection in Glaucoma Through the Concepts of Complementary Drug Therapy
Erb C
Klinische Monatsblätter für Augenheilkunde 2020; 237: 163-174
85085 Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
Montero-Oleas N
BMC complementary medicine and therapies 2020; 20: 12
85019 Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Wisely CE
Advances in Therapy 2020; 37: 1114-1123
85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Chen W
Frontiers in pharmacology 2020; 11: 302
84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Nemoto E
International journal of molecular sciences 2019; 21:
84802 Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
Rocha LR
Aging Cell 2020; 19: e13089
84522 Once Daily Pregabalin Eye Drops for Management of Glaucoma
Ibrahim MM
ACS nano 2019; 13: 13728-13744
85225 Safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis
Park CW
EXCLI journal 2020; 19: 187-200
85017 Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients
Sanz-González SM
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 120-129
85224 Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
Martin P
Clinical Ophthalmology 2020; 14: 885-896
84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Tan J
Molecular therapy. Methods & clinical development 2020; 17: 143-155
84662 Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Caruso C
International Ophthalmology 2019; 0:
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Yamamoto K
Scientific reports 2019; 9: 19288
85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Hommer N
Clinical Pharmacology and Therapeutics 2020; 0:
84662 Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Pacente L
International Ophthalmology 2019; 0:
84802 Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
Nguyen Huu VA
Aging Cell 2020; 19: e13089
85085 Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
Arevalo-Rodriguez I
BMC complementary medicine and therapies 2020; 20: 12
84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Wang X
Molecular therapy. Methods & clinical development 2020; 17: 143-155
85019 Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Sheng H
Advances in Therapy 2020; 37: 1114-1123
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Kokubun T
Scientific reports 2019; 9: 19288
84489 New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Sinha S
Eye 2020; 34: 72-88
85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Kallab M
Clinical Pharmacology and Therapeutics 2020; 0:
85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Yang X
Frontiers in pharmacology 2020; 11: 302

Issue 21-1

Select Issue


advertisement

WGW-2021